A decision was sent to Marlow Bottom Pharmacy on 31 May 2019 in respect of Quality Payments June 2018 Gateway Criteria
The Contractor has referred the dispute in relation to its GDS contract for dispute resolution under the provisions of paragraph 54 of Schedule 3 of the National Health Service (General Dental Services Contracts) Regulations 2015 (the “Regulations”).
By application dated 25 November 2017, Ascent Healthcare Ltd (“the Applicant”) applied to NHS Commissioning Board (“NHS England”) for inclusion in the pharmaceutical list offering identified improvements or better access under Regulation 17 within 200m radius of Caversham Lawn Tennis Club, Queensborough Drive, Reading, RG4 …
A decision dated 5 December 2018 was sent to Tilehurst Pharmacy in respect of FGF17.
As a GMS Provider, the above named contractor has referred the dispute of current market rent assessment as at 23 June 2015 for dispute resolution under the provision of Schedule 6, Part 7 of the NHS (General Medical Services Contract) Regulations 2004.
By application dated 10 June 2018, Maneph Resources Ltd (“the Applicant”) applied to NHS Commissioning Board (“NHS England”) for inclusion in the pharmaceutical list at Office Suite N, First Floor, The Kidlington Centre, High Street, Kidlington, OX5 2DL under Regulation 25.
By application dated 20 January 2018, Orange Private Limited (“the Applicant”) applied to NHS Commissioning Board (“NHS England”) for inclusion in the pharmaceutical list at 271 London Road, Reading, Berkshire, RG1 3NY under Regulation 25.
NHS England considered the discontinuation of arrangements for the provision of pharmaceutical services by Deddington Health Centre, following the decision to approve Rushport Advisory LLP’s application to open a pharmacy at The Studio, Hudson Street, Deddington OX15 0SW.
Navigate to more results pages
- Page: 1
- Page: 2